Literature DB >> 3769382

Stereoselective renal tubular secretion of quinidine and quinine.

D A Notterman, D E Drayer, L Metakis, M M Reidenberg.   

Abstract

Quinidine and quinine are stereoisomers. When given sequentially or simultaneously, the renal clearance of values of quinidine and quinine were measured in seven healthy volunteers and when given simultaneously, to an additional five elderly men. Analytic specificity was provided by an HPLC drug assay. Protein binding was measured by equilibrium dialysis. The quinidine clearance exceeded the quinine clearance in every individual. The mean (+/- SD) ratio of these clearances was 4.2 +/- 1.4 when the drugs were given together and 4.4 +/- 2.3 when they were given separately in the younger subjects and 3.4 +/- 0.5 when given simultaneously to the elderly. Calculating clearance of drug in serum water (unbound drug clearance) revealed a quinidine clearance of 6.1 +/- 2.3 times that of creatinine measured simultaneously, and for quinine it was 1.5 +/- 0.6 times that of creatinine. We conclude that there is stereoselective net renal tubular secretion of quinidine over quinine indicating stereoselectivity of this renal tubular transport process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3769382     DOI: 10.1038/clpt.1986.216

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

1.  Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.

Authors:  P Damkier; L L Hansen; K Brosen
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

Review 2.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

3.  Stereoselective inhibition of renal organic cation transport in human kidney.

Authors:  L T Wong; D D Smyth; D S Sitar
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 4.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 5.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

6.  Pharmacokinetics of quinine in patients with chronic renal failure.

Authors:  P Rimchala; J Karbwang; K Sukontason; V Banmairuroi; P Molunto; K Na-Bangchang
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

7.  Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

Authors:  L Borgström; L Nyberg; S Jönsson; C Lindberg; J Paulson
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

8.  Altered flecainide disposition in healthy volunteers taking quinine.

Authors:  A Munafo; G Reymond-Michel; J Biollaz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.

Authors:  G Muralidharan; E M Hawes; G McKay; E D Korchinski; K K Midha
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 10.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.